June 1, 2026 · conference presentation
JBIO conference presentation: a negative outcome, -11.6%
On June 1, 2026, Jade Biosciences, Inc. reached its conference presentation. The result was a negative outcome, and the stock moved -11.6% in the window around the event. It had already run -13.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$21.04
1d before
$18.59
Event day
$17.75
1d after
$16.94
5d after
Pre-catalyst setup
-13.2%
30-day run-up
5525%
30-day volatility
2.0×
volume spike